DNA-binding by oncoprotein E2A-Pbx1 is important for blocking differentiation but dispensable for fibroblast transformation

Oncogene

Volumn 12, Issue 1, 1996, Pages 19-30

  Kamps, M P ^a   Wright, D D ^a   Lu, Q ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Differentiation; E2A Pbx1; Leukemia; Oncoprotein

Indexed keywords

HOMEODOMAIN PROTEIN; ONCOPROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL DIFFERENTIATION; CELL TRANSFORMATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; FEMALE; FIBROBLAST; MOUSE; MYELOBLAST; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; PROTEIN DNA BINDING; T CELL LYMPHOMA; TRANSACTIVATION; TRANSCRIPTION INITIATION;

3T3 CELLS; ADENOVIRUS E2 PROTEINS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; DNA; DNA-BINDING PROTEINS; FEMALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS; RECOMBINANT FUSION PROTEINS; TRANS-ACTIVATION (GENETICS);

EID: 0030054255     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Adler SML, Waterman ML, He X and Rosenfeld MG. (1988). Cell, 52, 685-695.
2. Aronheim A, Shiran R, Rosen A and Walker M. (1993). Proc. Natl. Acad. Sci. USA, 90, 8063-8067.
3. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K. (1989). Current Protocols in Molecular Biology, 8.1.1-8.1.6.
4. Carroll A, Crist W, Parmley R, Roper M, Cooper M and Finley W. (1984). Blood, 63, 716-724.
5. Daley G, Van Etten R and Baltimore D. (1990). Science, 247, 824-830.
6. Dedera DA, Waller E, LeBrun D, Sen-Majumdar A, Stevens M, Barsh G and Cleary M. (1993). Cell, 74, 833-843.
7. Fitzpatrick VD, Percival-Smith A, Ingles CJ and Krause HM. (1992). Nature, 356, 610-612.
8. Gorman CM, Moffat LF and Howard BH. (1982). Mol.Cell. Biol.,2, 1044-1051.
9. Kamps MP, Murre C, Sun XH and Baltimore D. (1990). Cell, 60, 547-555.
10. Kamps MP, Look AT and Baltimore D. (1991). Genes & Dev., 5, 358-368.
11. Kamps MP and Baltimore D. (1993). Mol. Cell. Biol., 13, 351-357.
12. Kamps MP and Wright DD. (1994). Oncogene, 9, 3159-3166.
13. Kissinger CR. Liu B, Martin-Blanco E, Kornberg TB and Pabo CO. (1990). Cell, 63, 579-590.
14. Knoepfler P and Kamps MP. (1995). Mol. Cell. Biol., 15, 5811-5819.
15. Kunkel TA, Roberts JD and Zakour RA. (1987). Meth. Enzymol., 154, 367-378.
16. Lebrun DP and Cleary ML. (1994). Oncogene, 9, 1641-1647.
17. Lu Q and Kamps MP. (1996) Proc. Natl. Acad. Sci., in press.
18. Lu Q, Wright D and Kamps MP. (1994). Mol. Cell. Biol., 14, 3938-3948.
19. Lu Q, Knoepfler P, Scheele J, Wright DD and Kamps MP. (1995). Mol. Cell. Biol., 15, 3786-3795.
20. McGinnis W and Krunlauf R. (1992). Cell, 68, 283-302.
21. Monica K, Galili N, Nourse J, Saltman D and Cleary ML. (1991). Mol. Cell. Biol, 11, 6149-6157.
22. Monica K, LeBrun DP, Dedera D, Brown R and Cleary ML. (1994). Mol. Cell. Biol., 14, 8304-8314.
23. Nourse J, Mellentin JD, Galili N, Walkinson J, Standbridge E, Smith SD and Cleary ML. (1990). Cell, 60, 535-545.
24. Peers B, Sharma S, Johnson T, Kamps MP and Montminy M., (1995). Submitted
25. Popped H, Bienz M, Studer M, Chan S, Aparicio S, Brenner S, Mann R and Krumlauf R. (1995). Cell, 81, 1031-1042.
26. Quong M, Massari M, Zwart R and Murre C. (1993). Mol. Cell. Biol., 13, 792-800.
27. Van Dijk MA, Voorhoeve PM and Murre C. (1993). Proc. Natl.Acad. Sci. USA, 90, 6061-6065.
28. Van Dijk MA and Murre C. (1994). Cell, 78, 617-624.
29. Wigler M, Sweet R, Kim GK, Wold B, Pellicer A, Lacy E, Maniatis T, Silverstein S and Axel R. (1979). Cell, 16, 777-785.
30. Wolberger C, Vershon A, Liu B, Johnson A and Pabo C. (1991). Cell, 67, 517-528.
31. Vershon A, Jin Y and Johnson A. (1995). Genes & Devel., 9, 182-192.
32. Williams D, Look A, Melvin S, Roberson P, Dahl G, Flake T and Srass S. (1984). Cell, 36, 101-109.